**Core tip:** Diarrhea-predominant irritable bowel syndrome (D-IBS) is a chronic functional gastrointestinal disease. Abnormal ion secretion of colonic mucosal epithelial cells is recognized as one of the pathophysiological factors. In this paper, through the observation of TongXie-YaoFang (TXYF) formula, a Chinese herbal formula, to D-IBS rats obtained by neonatal maternal separation plus restraint stress. The mucosal stripping under a microscope was used for tissue preparation. Short-circuit current technology was used for testing 5-HT-induced changes in the current across ion channels of colonic epithelium. The results indicated that TXYF-formula could regulate the secretion of Cl^-^ and HCO~3~^-^ in colonic mucosa *via* cystic fibrosis transmembrane conductance regulator (CFTR) Cl^-^ channel, Cl^-^/HCO~3~^-^ exchanger, Na^+^-HCO~3~^-^ co-transporter and Na^+^-K^+^-2Cl^-^ co-transporter co-transporters.

INTRODUCTION
============

Diarrhea-predominant irritable bowel syndrome (D-IBS) is a chronic functional gastrointestinal disease. Its clinical manifestations are characterized by diarrhea and abdominal pain or discomfort in the absence of a demonstrable pathology. The diagnosis of D-IBS is based on symptom assessment and the Rome III Diagnostic Criteria\[[@B1],[@B2]\]. According to an epidemiological study, D-IBS mainly affects young adults of 20-40 years old, and the quality of their lives is seriously affected\[[@B3]\].

The pathogenesis of D-IBS has not been fully clarified. Consequently, the usual treatment of the disease in Western medicine involves symptomatic therapy, which is unsatisfactory for patients while simultaneously increasing the use of health-care resources\[[@B4]-[@B6]\]. Because traditional Chinese medicine (TCM) can significantly improve patients' symptoms and quality of life, increasing numbers of patients have begun to seek treatment with TCM\[[@B7],[@B8]\].

A series of randomized, double-blind, placebo-controlled trials had shown that TongXie-YaoFang (TXYF) formula can significantly improve the clinical symptoms, such as diarrhea and abdominal pain or discomfort, of patients with D-IBS and improve the quality of their lives\[[@B9],[@B10]\]. However, the specific mechanism of it has not been completely elaborated. The purpose of this paper is to observe the regulating effects of TXYF-formula on colonic epithelial secretion *via* relevant ion channels.

MATERIALS AND METHODS
=====================

Animals
-------

Neonatal Sprague Dawley rats, postnatal day 1, were purchased from Vital River Laboratories Animal Technology Co., Ltd. (Beijing, China; Number of qualitative qualification: 11400700015068, 11400700019786), and kept at Dongzhimen Hospital Affiliated with Beijing University of Chinese Medicine \[Number of permit: SYXK(Beijing)2009.0028\]. In this study, only male litters were used to eliminate the impact of estrogen and hormones on the secretory and sensory responses of the intestine to excitants\[[@B11]\]. Then the pups were randomly assigned to one of the following two rearing conditions: (1) neonatal maternal separation plus restraint stress (NMS + RS); or (2) no handling or separation (NH).

Neonatal maternal separation plus restraint stress
--------------------------------------------------

On postnatal days 2-21, the NMS + RS litters were removed from their cages and separated from their dams for 180 min each day, whereas NH pups remained in their home cages\[[@B12],[@B13]\]. Manipulation began at 0900 h ± 30 min each day to minimize the influence of circadian rhythms. During the 180 min period of separation, pups were removed from the nest to stand-alone compartments, where the temperature was maintained at 23 °C ± 0.5 °C in a thermally regulated facility. The compartments contained bedding of 2.5 cm wood chips and were adjacent to their home cages. The litters were returned to their home cages immediately after separation. All the rats were reared on a 12:12 h light-dark cycle (lights on at 0800 h) with access to food and water ad libitum. On day 22, sexes of the pups, including those in NH group, were distinguishable, so the females were removed and the males retained. On day 22, NMS + RS and NH rats were weaned and kept in individual cages with only 3-4 pups per cage. After weaning, pups were weighed once a week until the end of experiment. Manipulations were performed in the morning with the same measuring instrument and at the same location.

On days 50-59, NMS + RS rats were placed in transparent plastic restraint cylinders (4 cm × 4 cm × 18 cm), in which they could move forward and backward but could not turn around\[[@B14]\]. The rats remained in the restraint cylinders for 3 h, with access to food and water ad libitum, in the morning and in the afternoon of each day. Then NMS + RS rats were divided into two groups (NMS + RS group and TXYF-formula group).

All animal care and experimental procedures were conducted according to the institutional ethical guidelines and conformed to the requirements of the Institutional Animal Care and Use Committee of Beijing University of Chinese Medicine and the Animal Ethics Committee of Dongzhimen Hospital Affiliated with Beijing University of Chinese Medicine.

TXYF Composition and administration
-----------------------------------

TXYF-formula consisted of the following four Traditional Chinese Herbal Medicines: Bai Zhu (Atractylodesm macrocephala Koidz - Acta Horti Gothoburgensis 12(9): 310 1938)-93.75 g, Shao Yao (Paeonia lactiflora Pall. - Reise Russ. Reich. 3: 286. 1776)-62.5 g, Chen Pi (Citrus reticulata Blanco - Fl. Filip. 610 1837.)-46.875 g and Fang Feng (Saposhnikovia divaricata (Turcz.) Schischk. - Fl. URSS 17: 359 1951.)-31.25 g. It was manufactured by Preparation Room for TCM of Beijing Chinese Medicine Hospital. All formula raw materials were examined according to the quality control criteria in Chinese Pharmacopeia\[[@B15]\].

From postnatal day 60, rats in TXYF-formula group were daily given orally administered TXYF-formula (4.92 g/100 g bodyweight) while NH group and NMS + RS group were treated with distilled water. The delivery volume in three groups was 2 mL/100 g per day, for 14 consecutive days.

Tissue preparation
------------------

After treatment, the rats in three groups were first anesthetized abdominally with 7% chloral hydrate (35 mg/100 g bodyweight). The distal colon (6-7 cm from anus) was then quickly removed and incised longitudinally along the mesenteric border. The mucosa was fixed onto a Petri dish with silica gel in the bottom, with the lumen side down. The Petri dishes were filled with Krebs' solution under 95% oxygen and 5% carbon dioxide. The mucosal layer was carefully separated from the submucosa, muscularis, and serosal layer with fine tweezers under a microscope. The mucosal layer was then cut into small flat sheets, with areas of about 0.5 cm^2^, for further analysis. Two sheets could be obtained from one segment of the distal colon.

Ussing chamber experiments
--------------------------

Six adjacent tissues from the distal colon of each rat were obtained and mounted in Ussing chambers. Krebs' solution (5 mL) was injected into two small adjacent compartments with circulating 95% oxygen and 5% carbon dioxide while pH was maintained at 7.35-7.45 and temperature at 37 °C. The tissues were left to equilibrate for 60 min to allow the electrical parameters to stabilize. The voltage across tissues was then clamped to zero and the short-circuit current (Isc, μA/cm^2^) was measured. When the Isc baseline was smooth, 10 µmol/L indomethacin was added to basolateral side of the tissue and maintained for 10 min to block the influence of endogenous prostaglandins\[[@B16],[@B17]\]. The Isc value was recorded at this time. 5-HT (10 µmol/L) was then added to basolateral side and the maximum Isc recorded. The change in Isc (∆Isc) after the addition of 5-HT was then calculated. To measure the transmembrane resistance (Rt, Ω/cm^2^), electrical stimulation of 1 mV was applied to both sides of the epithelium. Tissue conductance was calculated according to Ohm's law and expressed in milliSiemens per square centimeter (mS/cm^2^). The drugs or specific blockers were then applied to the apical or basolateral side of tissue and the ∆Isc of ion channels in colonic epithelium were calculated and recorded for further analysis.

Reagents
--------

Krebs' solution of the following composition (in mol/L): 117 NaCl, 4.7 KCl, 1.2 MgCl~2~, 24.8 NaHCO~3~, 1.2 KH~2~PO~4~, 2.56 CaCl~2~, and 11.1 glucose; Krebs' solution without Cl^-^: sodium gluconate instead of NaCl, potassium gluconate instead of KCl, calcium gluconate instead of CaCl~2~, and the remaining components were the same; Krebs' solution without HCO~3~^-^: 141.8 NaCl, 5.9 KCl, 1.2 MgSO~4~∙7 H~2~O, 2.56 CaCl~2~, 11.1 glucose, 10 HEPES free acid, and 5.6 Tris. Krebs' solution without Cl^-^ and HCO~3~^-^: sodium gluconate instead of NaCl and NaHCO~3~, potassium gluconate instead of KCl, calcium gluconate instead of CaCl~2~, and the remaining components were the same. 5-HT, batch number: 1001156278; Glibenclamide, batch number: 1001068037; Indomethacin, batch number: 1001087688; Bumetanide, batch number: 101016760; Amiloride, batch number: 101093389; SITS (4-acetamido-4′-isothio-cyanato-stilbene-2,2′-disulfonic), batch number: 1001208418; DPC (1,1-dimethyl piperidinium chloride), batch number: 101078880; BaCl~2~, batch number: 1398; DIDS (4,4′-diisothiocyanato-stilbene-2,2′-disulfonic acid), batch number: 1001339605. cystic fibrosis transmembrane conductance regulator (CFTR)(inh)-172, batch number: 6311. All reagents were purchased from Sigma-Aldrich Co.

Apparatus
---------

A multichannel voltage-current clamp (VCC MC6) was purchased from Physiologic Instruments Corporation; the Bridge amplifier (ML228), recording and analysis system for physiological data (Power Lab) was purchased from AD Instruments Corporation.

Statistical analysis
--------------------

All experimental data were analyzed by SPSS 17.0 statistical software and expressed as means ± SE. The differences between groups were analyzed with a paired *t* test. *P* \< 0.05 was considered statistically significant.

RESULTS
=======

Basic electrophysiological properties of colonic mucosa in three groups were undifferentiated
---------------------------------------------------------------------------------------------

The basic Isc did not differ significantly between three groups (21.02 µA/cm^2^± 2.92 µA/cm^2^*vs* 20.29 µA/cm^2^± 3.58 µA/cm^2^*vs* 20.71 µA/cm^2^± 2.04 µA/cm^2^, *n* = 18, *P* \> 0.05, respectively; Figure [1A](#F1){ref-type="fig"}). The basic voltage in three groups had similar results (3.49 mV ± 0.54 mV *vs* 3.52 mV ± 0.69 mV *vs* 3.57 mV ± 0.62 mV, *n* = 18, *P* \> 0.05, respectively; Figure [1B](#F1){ref-type="fig"}) as well as the basic resistance (166.8 Ω/cm^2^± 20.11 Ω/cm^2^*vs* 173.66 Ω/cm^2^± 16.39 Ω/cm^2^*vs* 171.94 Ω/cm^2^± 19.03 Ω/cm^2^, *n* = 18, *P* \> 0.05, respectively; Figure [1C](#F1){ref-type="fig"}). The 5-HT-induced change of short-circuit current (∆Isc) in NMS + RS group was respectively smaller than that in NH group and TXYF-formula group (38.8 µA/cm^2^± 7.25 µA/cm^2^*vs* 70.86 µA/cm^2^± 12.32 µA/cm^2^, 67.67 µA/cm^2^± 11.68 µA/cm^2^, *n* = 18, *P* \< 0.01, respectively; Figure [1D](#F1){ref-type="fig"}).

![Comparison of basic electrophysiological properties of colonic mucosa in rats and 5-HT-induced the changes of short-circuit current among three groups. A-C: The basic Isc, basic voltage and basic resistance did not differ significantly between three groups, respectively (*P* \> 0.05, respectively); D: TXYF-formula significantly increased 5-HT-induced ∆Isc in neonatal maternal separation plus restraint stress (NMS + RS) rats. ^b^*P* \< 0.01 *vs* NMS + RS group. Isc: The short-circuit current; ∆Isc: The changes of Isc; TXYF: TongXie-YaoFang; NMS: Neonatal maternal separation; RS: Restraint stress; NH: No handlings as control.](WJG-22-10584-g001){#F1}

5-HT-induced ∆Isc after the effects of CFTR Cl^-^ channel or Na^+^-K^+^-2Cl^-^ co-transporter blocker was similar in three groups. ∆Isc was higher in TXYF- formula group than in NMS + RS group after the effects of Ca^2+^-dependent Cl^-^ channel or epithelial Na^+^ channel blocker
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DPC or Glibenclamide with final concentration 1 mmol/L were respectively added to apical side, namely left side of Ussing chamber, of colonic mucosa and equilibrated for 30 min. Then 10 µmol/L 5-HT was added to basolateral side (Equilibrated time and added concentration of 5-HT was same in the following experiment). ∆Isc induced by 5-HT were similar in TXYF-group and NMS + RS group, respectively (47.75 µA/cm^2^± 7.99 µA/cm^2^*vs* 42.28 µA/cm^2^± 10.61 µA/cm^2^, 57.57 µA/cm^2^± 14.25 µA/cm^2^*vs* 46.78 µA/cm^2^± 11.68 µA/cm^2^, *n* = 8, *P* \> 0.05, respectively; Figure [2A](#F2){ref-type="fig"}). The similar result was obtained when CFTR(inh)-172 was added to apical side with final concentration 100 µmol/L (45.04 µA/cm^2^± 9.18 µA/cm^2^*vs* 36.2 µA/cm^2^± 9.64 µA/cm^2^, *n* = 8, *P* \> 0.05; Figure [2A](#F2){ref-type="fig"}).

![Effects of 1,1-dimethyl piperidinium chloride, Glibenclamide, cystic fibrosis transmembrane conductance regulator(inh)-172, 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid, Amiloride and Bumetanide on 5-HT-induced the changes of short-circuit current in rats. A: After the intervention with DPC, Glibenclamide or CFTR(inh)-172, respectively, ∆Isc induced by 5-HT were similar in three groups (*P* \> 0.05, respectively); B: 5-HT-induced ∆Isc was higher in TXYF-formula group than in NMS + RS group after the intervention with DIDS or Amiloride. ^a^*P* \< 0.05 *vs* NMS + RS group; ^b^*P* \< 0.01 *vs* NMS + RS group. DPC: 1,1-dimethyl piperidinium chloride; CFTR: Cystic fibrosis transmembrane conductance regulator; ∆Isc: the changes short-circuit current; DIDS: 4,4′-diisothiocyanato-stilbene-2,2′-disulfonic acid; TXYF: TongXie-YaoFang; NMS: Neonatal maternal separation; RS: Restraint stress; NH: No handlings as control.](WJG-22-10584-g002){#F2}

5-HT-induced ∆Isc was higher in TXYF-formula group than in NMS + RS group after the effects of Ca^2+^-dependent Cl^-^ channel (CACC) blocker DIDS (500 µmol/L, added to apical side) or epithelial Na^+^ channel (ENaC) blocker Amiloride (100 µmol/L, added to apical side), respectively (69.22 µA/cm^2^± 11.7 µA/cm^2^*vs* 48.41 µA/cm^2^± 13.15 µA/cm^2^, 62.11 µA/cm^2^± 12.01 µA/cm^2^*vs* 44.69 µA/cm^2^± 12.58 µA /cm^2^, *n* = 8, *P* \< 0.05, respectively; Figure [2B](#F2){ref-type="fig"}). There were no statistical differences in three groups when 100 µmol/L Na^+^-K^+^-2Cl^-^ co-transporter (NKCC) blocker Bumetanide was added to basolateral (37.64 µA/cm^2^± 10.57 µA/cm^2^*vs* 27.55 µA/cm^2^± 10.94 µA/cm^2^*vs* 29.43 µA/cm^2^± 7.66 µA/cm^2^, *n* = 8, *P* \> 0.05; Figure [2B](#F2){ref-type="fig"}).

There were no significant differences in three groups after the effects of K^+^ channel blocker, Na^+^-HCO~3~^-^ co-transporter blocker or Cl^-^/HCO~3~^-^ exchanger inhibitor on 5-HT-induced ∆Isc
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

∆Isc induced by 5-HT were similar in three groups when 5 mmol/L K^+^ channel blocker BaCl~2~ or 100 µmol/L Cl^-^/HCO~3~^-^ exchanger inhibitor SITS was respectively added to basolateral side of colonic mucosa (25.63 µA/cm^2^± 13.69 µA/cm^2^*vs* 13.92 µA/cm^2^± 8.16 µA/cm^2^*vs* 17.03 µA/cm^2^± 9.04 µA/cm^2^, 49.92 µA/cm^2^± 11.66 µA/cm^2^*vs* 40.41 µA/cm^2^± 14.26 µA/cm^2^*vs* 47.7 µA/cm^2^± 11.43 µA/cm^2^, *n* = 8, *P* \> 0.05, respectively; Figure [3](#F3){ref-type="fig"}). There was also no statistical difference in three groups after the effects of 200 µmol/L Na^+^-HCO~3~^-^ co-transporter (NBC) blocker DIDS (500 µmol/L, added to basolateral side) (12.27 µA/cm^2^± 3.6 µA/cm^2^*vs* 10.74 µA/cm^2^± 2.99 µA/cm^2^*vs* 11.88 µA/cm^2^± 3.51 µA/cm^2^, *n* = 8, *P* \> 0.05; Figure [3](#F3){ref-type="fig"}).

![Effects of BaCl~2~, 4-acetamido-4'-isothio-cyanato-stilbene-2,2'-disulfonic and 4,4′-diisothiocyanato-stilbene-2,2′-disulfonic acid on 5-HT-induced the changes of short-circuit current in rats. 5-HT-induced ∆Isc were similar in three groups after the intervention with BaCl~2~, SITS or DIDS, respectively (*P* \> 0.05, respectively). ∆Isc: the changes short-circuit current; SITS: 4-acetamido-4′-isothio-cyanato-stilbene-2,2′-disulfonic; DIDS: 4,4′-diisothiocyanato-stilbene-2,2′-disulfonic acid; TXYF: TongXie-YaoFang; NMS: Neonatal maternal separation; RS: Restraint stress; NH: No handlings as control.](WJG-22-10584-g003){#F3}

5-HT-induced ∆Isc was higher in TXYF-formula group than in NMS + RS group when Na^+^ in apical side of colonic mucosa was taken out. This phenomenon disappeared while Cl^-^ and HCO~3~^-^ were taken out altogether or respectively
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

When Na^+^ applied to apical side of colonic mucosa was substituted with sodium gluconate, 5-HT-induced ∆Isc was higher in TXYF-formula groups than in NMS + RS group (56.86 µA/cm^2^± 11.2 µA/cm^2^*vs* 39.14 µA/cm^2^± 10.83 µA/cm^2^, *n* = 8, *P* \< 0.05; Figure [4A](#F4){ref-type="fig"}). However, when basolateral side Na^+^ was substituted with sodium gluconate, ∆Isc was similar in three groups (0.87 µA/cm^2^± 0.33 µA/cm^2^*vs* 1.15 µA/cm^2^± 0.5 µA/cm^2^*vs* 1.01 µA/cm^2^± 0.49 µA/cm^2^, *n* = 8, *P* \> 0.05, respectively; Figure [4B](#F4){ref-type="fig"}).

![Effects of Na^+^, Cl^--^ and HCO~3~^--^ on 5-HT-induced the changes of short-circuit current in rats. A: 5-HT-induced ∆Isc was higher in TXYF-formula group than in NMS + RS group when Na^+^ in apical side of colonic mucosa was taken out; B: When Na^+^ in basolateral side was taken out, ∆Isc was similar in three groups; C: 5-HT-induced ∆Isc was similar in three groups when Cl^--^ and HCO~3~^--^ was respectively or entirely removed from basolateral side of colonic mucosa. ^a^*P* \< 0.05 *vs* NMS + RS group; ^b^*P* \< 0.01 *vs* NMS + RS group. ∆Isc: the changes short-circuit current; TXYF: TongXie-YaoFang; NMS: Neonatal maternal separation; RS: Restraint stress; NH: No handlings as control.](WJG-22-10584-g004){#F4}

5-HT-induced ∆Isc was similar in three groups when Cl^-^ and HCO~3~^-^ was respectively removed from basolateral side of colonic mucosa (14.42 µA/cm^2^± 6.07 µA/cm^2^*vs* 15.95 µA/cm^2^± 5.64 µA/cm^2^*vs* 15.09 µA/cm^2^± 4.04 µA/cm^2^, 33.86 µA/cm^2^± 7.47 µA/cm^2^*vs* 26.54 µA/cm^2^± 8.9 µA/cm^2^*vs* 31.88 µA/cm^2^± 6.07 µA/cm^2^, *n* = 8, *P* \> 0.05, respectively; Figure [4C](#F4){ref-type="fig"}). When both Cl^-^ and HCO~3~^-^ were simultaneously removed from Krebs' solution applied to basolateral side, 5-HT-induced ∆Isc was similar in three groups (8.38 µA/cm^2^± 1.15 µA/cm^2^*vs* 9.3 µA/cm^2^± 2.16 µA/cm^2^*vs* 8.51 µA/cm^2^± 1.2 µA/cm^2^, *n* = 8, *P* \> 0.05, respectively; Figure [4C](#F4){ref-type="fig"}).

DISCUSSION
==========

The etiology and pathogenesis of D-IBS are complex, and its pathophysiological changes predominantly include dynamic gastrointestinal disorder and visceral sensory sensitivity. In TCM, D-IBS is classified as diarrhea or abdominal pain according to its clinical manifestations\[[@B18]\]. Previous studies had shown that TXYF-formula had an inhibitory effect on bowel movement and reduced intestinal peristalsis by regulating 5-HT\[[@B19],[@B20]\]. Pharmacological study showed that Fang Feng could increase intestinal pressure threshold in rats so that to present its analgesic effect\[[@B21]\]. In this study, we used the method of neonatal maternal separation plus restraint stress to establish an animal mode of D-IBS, with the main simultaneous symptoms of diarrhea and high visceral sensitivity. This recapitulates the clinical symptoms of patients with D-IBS.

The secretion activities induced by 5-HT in colonic mucosae of NMS + RS rats were weaker than those in NH rats or TXYF-formula-treated rats in this study. This may be related to increased 5-HT and 5-HT-receptor levels in NMS + RS rats. When 5-HT was added to colonic mucosa from NMS + RS rats, the electrical activities across epithelium declined. The reaction to 5-HT in colonic mucosae of rats was restored by treatment with TXYF-formula, to a level almost the same as that observed in NH rats. This demonstrates that TXYF-formula has specific therapeutic effects on D-IBS.

We found that one of the therapeutic effects of TXYF-formula is achieved by regulating secretion of Cl^-^. The specific results were as follows: 5-HT-induced ∆Isc in NMS + RS rats differed significantly from that in TXYF-formula group and NH group when extracellular Cl^-^ was not removed. However, when extracellular Cl- was removed, the difference disappeared. When a CFTR Cl- channel blocker was added to apical side or an NKCC co-transporter inhibitor was added to basolateral side of tissue, ∆Isc did not differ statistically in NMS + RS and TXYF-formula-treated rats. In presence of the nonselective K^+^ channel blocker\[[@B22]\], 5-HT-induced ∆Isc did not differ significantly between NMS + RS group and TXYF-formula group. This indicates that Cl^-^ secretion by mucosal epithelium is dependent on electrochemical gradient across the serosal surface generated by K^+^ transport.

We also found that TXYF-formula alters HCO~3~^-^ secretion. When extracellular HCO~3~^-^ was removed or NBC was inhibited, 5-HT-induced ∆Isc did not differ between NMS + RS group and TXYF-formula group. The same result was obtained when extracellular Cl^-^ and HCO~3~^-^ were both removed or when Cl^-^/HCO~3~^-^ exchange was interrupted. Thus, the therapeutic effect of TXYF-formula is achieved by regulating the secretion of both Cl^-^ and HCO~3~^-^. Moreover, when Na^+^ on apical side of membrane was removed or a Na^+^ channel blocker was added, ∆Isc still differed between NMS + RS group and TXYF-formula group; and the differences between NMS + RS and NH rats did not disappear. Therefore, the relationship between therapeutic effects of TXYF-formula on Na^+^ transport and D-IBS is not close. Nevertheless, after Na+ in basilar membrane was removed, the electrical activity across epithelium did not differ between TXYF-formula group and NMS + RS group. Therefore, it can be seen that the regulatory effects of TXYF-formula on Cl^-^ and HCO~3~^-^ secretion depends on Na^+^ in basilar membrane.

There are two main types of Cl^-^ channels on apical side of epithelial cells: CFTR and CACC. CFTR is a cAMP-dependent, PKA-activated Cl^-^ channel, and is sensitive to DPC and Glibenclamide\[[@B23],[@B24]\]. After CFTR Cl^-^ channel was blocked by DPC or Glibenclamide, the electrical activity across epithelium induced by 5-HT did not differ obviously between TXYF-formula group and NMS + RS group. However, the electrical activity in two groups differed markedly after the application of CACC blocker DIDS. Therefore, the regulatory effect of TXYF-formula on electrical activity across epithelia of D-IBS rats is associated with CFTR Cl^-^ channel, and has nothing to do with CACC channel.

Our results, combined with preliminary studies\[[@B25],[@B26]\] about secretory mechanisms of epithelial anions in colonic mucosa, allow the following conclusions to be drawn. The regulating effects of TXYF-formula on D-IBS involves the secretion of Cl^-^ and HCO~3~^-^ in colonic mucosa *via* CFTR Cl^-^ channel, Cl^-^/HCO~3~^-^ exchanger, and NBC and NKCC co-transporters.

COMMENTS
========

Background
----------

Diarrhea-predominant irritable bowel syndrome (D-IBS) is a chronic functional gastrointestinal disease. The pathogenesis of it has not been thoroughly elucidated while colonic abnormal secretory is recognized as one of the pathophysiological factors. The usual treatment in Western medicine, mainly involves symptomatic therapy, is unsatisfactory for patients while simultaneously increasing the use of health-care resources. Traditional Chinese medicine (TCM) can obviously alleviate patients' clinical symptoms, increasing numbers of them have begun to seek treatment with TCM. A lot of researches have shown that TongXie-YaoFang formula (TXYF-formula), a Chinese herbal formula, can significantly improve D-IBS patients' clinical symptoms and enhance their quality of lives.

Research frontiers
------------------

TXYF-formula is a Traditional Chinese classical prescription for clinical treatment on D-IBS. The research hotspot is its effect on colonic abnormal secretory *via* correlational ion channels, visceral sensitivity and colon movement.

Innovations and breakthroughs
-----------------------------

Previous clinical and experimental studies had only shown that TXYF-formula can relieve diarrhea of patients with D-IBS. Its correlational effects might be realized by influencing secretion of colon. However, the specific mechanism and correlative ions are unclear. In this study, the mucosal stripping under a microscope was used for tissue preparation. And short-circuit current technology was applied to observe 5-HT-induced changes in current across ion channels of colonic epithelium so as to reveal the prescription effect of TXYF-formula ion transport in colon.

Applications
------------

The key results of this study showed that TXYF-formula can regulate the secretion of Cl^-^ and HCO~3~^-^ in colonic mucosa of D-IBS rats. And this may be related to cystic fibrosis transmembrane conductance regulator (CFTR) Cl^-^ channel, Cl^-^/HCO~3~^-^ exchanger, and Na^+^-HCO~3~^-^ co-transporter (NBC) and Na^+^-K^+^-2Cl^-^ co-transporter (NKCC) co-transporters.

Terminology
-----------

D-IBS, as a clinically common functional gastrointestinal disease, is closely related to early adverse life events. It seriously affects patient's quality of jobs and lives. TXYF-formula can regulate the Cl^-^ and HCO~3~^-^ secretion of colonic mucosa *via* CFTR Cl^-^ channel, Cl^-^/HCO~3~^-^ exchanger, NBC and NKCC co-transporters.
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